
INCYTE CORP
Nasdaq · Services-Commercial Physical & Biological Research
Company Overview
A concise company profile alongside the latest public filing activity.
Incyte Corporation is a biopharmaceutical company that discovers, develops, and commercializes medicines, with a focus on oncology and inflammation and autoimmunity treatments. Its products include Jakafi, used to treat certain blood disorders, along with a pipeline of other therapies developed through its own research and licensing partnerships.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| CAGNONI PABLO JPresident, Global Head of R&D | Sell | $298K | 2,642at $112.71 | Oct 15, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable INCY activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.